SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520262-17-000039
Filing Date
2017-07-27
Accepted
2017-07-27 09:01:11
Documents
65
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20170630x10q.htm 10-Q 1922197
2 EX-31.1 alks-20170630ex311e07b0a.htm EX-31.1 47474
3 EX-31.2 alks-20170630ex312bec741.htm EX-31.2 47568
4 EX-32.1 alks-20170630ex32189aa9f.htm EX-32.1 21135
5 GRAPHIC alks20170630x10q001.jpg GRAPHIC 4994
6 GRAPHIC alks20170630x10q002.jpg GRAPHIC 24297
7 GRAPHIC alks20170630x10q003.jpg GRAPHIC 13438
8 GRAPHIC alks20170630x10q004.jpg GRAPHIC 91083
  Complete submission text file 0001520262-17-000039.txt   6919324

Data Files

Seq Description Document Type Size
9 EX-101.INS alks-20170630.xml EX-101.INS 1505057
10 EX-101.SCH alks-20170630.xsd EX-101.SCH 36723
11 EX-101.CAL alks-20170630_cal.xml EX-101.CAL 66467
12 EX-101.DEF alks-20170630_def.xml EX-101.DEF 115476
13 EX-101.LAB alks-20170630_lab.xml EX-101.LAB 402262
14 EX-101.PRE alks-20170630_pre.xml EX-101.PRE 261126
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 17984685
SIC: 2834 Pharmaceutical Preparations